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Background: Epithelial ovarian-cancer (EOC) is a heterogeneous disease which 
constitutes an area of unmet need. Continuous monitoring of molecular physiology of 
the disseminated tumour deposits would help to evaluate early tumour response to 
chemotherapy and profiling of spatial tumour heterogeneity in advanced stage 
disease. Methods:  Surgically removed cancerous and non cancerous omentum is 
tested ex vivo. The omentum, cut into 1cm3 pieces, is placed in RPMI cell culture 
media. A liquid junction potential measuring system is used, consisting of a Ag/AgCl 
reference electrode, and a differential amplifier. After digestion with dispase 
extracted cells are stained with cell type specific markers and the proportion of 
cancerous cells are calculated. Statistical significance was calculated with the Mann 
Whitney U-test. Results: 12 EOC-patients were evaluated. On 12 pairs of cancerous 
and non-cancerous omentum samples the average biopotential of the non-
cancerous and cancerous omentum was 1.43v and 1.07v, respectively, showing a 
statistically significant difference of 0.36v (p = 0.05). The biopotential of the non-
cancerous omentum ranged between 1.20v and 1.73v, versus 0.63v to 1.48v in the 
cancerous omentum, showing an overlap between 1.20v and 1.48v. In all 12 
samples, the biopotential of the non-cancerous omentum was always greater than 
the cancerous omentum. The biopotential difference between the cancerous and 
non-cancerous omentum ranged from 0.15v to 0.87v. 10 of the 12 (83.3%) cases 
had a difference < 0.6v, which correlated with good surgical & clinical 
patients´outcome in terms of residual disease, and surgical morbidity and 3-mo 
mortality. Patients with biopotential difference > 0,6v had poor surgical and clinical 
outcome. Conclusions:  The characterisation of EOC parameters that are 
detectable by electronic sensors will facilitate the development of devices to better 
monitor the disease and predict treatment outcomes. It appears that the biopotential 
difference between the cancerous and non-cancerous omentum, above a specific 
cut-off of 0.6v may be associated with an adverse surgical and clinical outcome. 
Larger scale measurements are warranted to confirm this hypothesis into a proof of 
concept. 
 
